MAIA Biotechnology, Inc. entered into a Securities Purchase Agreement with three institutional accredited investors for a registered direct offering of 2,424,243 shares of common stock at a price of $1.65 per share, and also agreed to issue unregistered warrants to purchase up to 2,424,243 shares of common stock.